Comparison of Insulin Glargine/Insulin Glulisine Regimen to Insulin Aspart/Insulin Aspart Protamine 30/70 in Type 2 Diabetes Mellitus Patients (T2DM)

NCT01212913 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

161

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: INSULIN GLARGINE
DRUG: INSULIN GLULISINE
DRUG: Insulin aspart

Sponsor

Sanofi